543906-09-8 Usage
Uses
Used in Pharmaceutical Industry:
(3aR,4S,7aR)-Octahydro-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]-1H-indole-1-carboxylic acid methyl ester is used as a pharmaceutical compound for its potential therapeutic effects. Its unique structure may allow it to interact with specific biological targets, such as receptors or enzymes, which could be beneficial in the treatment of various diseases.
Used in Chemical Research:
In the field of chemical research, (3aR,4S,7aR)-Octahydro-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]-1H-indole-1-carboxylic acid methyl ester can be used as a starting material or a building block for the synthesis of more complex molecules. Its unique structural features may enable the development of novel compounds with enhanced properties and applications.
Used in Drug Delivery Systems:
Similar to gallotannin, (3aR,4S,7aR)-Octahydro-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]-1H-indole-1-carboxylic acid methyl ester could potentially be incorporated into drug delivery systems to improve its bioavailability and therapeutic efficacy. By utilizing various carriers, such as organic or metallic nanoparticles, the compound could be more effectively delivered to target cells or tissues, enhancing its overall performance in treating specific conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 543906-09-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,4,3,9,0 and 6 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 543906-09:
(8*5)+(7*4)+(6*3)+(5*9)+(4*0)+(3*6)+(2*0)+(1*9)=158
158 % 10 = 8
So 543906-09-8 is a valid CAS Registry Number.
543906-09-8Relevant articles and documents
AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: Identification, SAR and pharmacological characterization
Vranesic, Ivo,Ofner, Silvio,Flor, Peter Josef,Bilbe, Graeme,Bouhelal, Rochdi,Enz, Albert,Desrayaud, Sandrine,McAllister, Kevin,Kuhn, Rainer,Gasparini, Fabrizio
, p. 5790 - 5803 (2015/01/09)
Here we describe the identification, structure-activity relationship and the initial pharmacological characterization of AFQ056/mavoglurant, a structurally novel, non-competitive mGlu5 receptor antagonist. AFQ056/mavoglurant was identified by chemical der